by McKesson Ventures | Apr 27, 2020 | Portfolio News
GRAIL has announced that new data for its investigational multi-cancer early detection blood test will be presented at the American Association for Cancer Research (AACR) Virtual Annual Meeting. These new data evaluate the performance of GRAIL’s test in symptomatic...
by McKesson Ventures | Mar 31, 2020 | Portfolio News
GRAIL today announced that validation data for its multi-cancer early detection blood test were published in Annals of Oncology. These data show that GRAIL’s technology can detect more than 50 cancer types across all stages, with a false positive rate of less than 1%,...
by McKesson Ventures | Dec 18, 2019 | Portfolio News
GRAIL Inc., a health care company whose mission is to detect cancer early, when it can be cured, recently announced the appointment of Gautam Kollu as Chief Commercial Officer. “We are very pleased to welcome Gautam, who brings extensive experience in accelerating...
by McKesson Ventures | Oct 8, 2019 | Portfolio News
GRAIL, a health care company whose mission is to detect cancer early, announced new data validating the performance of its investigational multi-cancer early detection blood test for the first time in an independent cohort of participants. The results from the...
by McKesson Ventures | Aug 27, 2019 | Portfolio News
GRAIL, Inc., a health care company whose mission is to detect cancer early, when it can be cured, announced that Rodger Currie, JD, has been appointed as Vice President and Head of Government Affairs and Alliance Development. Currie will report to Joshua Ofman, MD,...
